The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

Launched by THE UNIVERSITY OF HONG KONG · Feb 17, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how the COVID-19 pandemic has affected the health and healthcare of people with long-term health conditions, like diabetes, heart disease, and cancer. The goal is to understand the indirect effects of COVID-19 on these patients, even if they did not get the virus themselves. Researchers will look at health records and conduct surveys in hospitals and clinics in Hong Kong from 2010 to 2024 to gather information about what has happened to these patients’ health and their use of healthcare services during and after the pandemic.

To participate in the study, individuals need to be at least 18 years old and have a diagnosed non-communicable disease (like those mentioned above) and should have visited a public hospital or clinic at least once between January 2010 and December 2024. Importantly, anyone who has been diagnosed with COVID-19 will not be eligible to join. Participants can expect to share their health experiences and contribute to important research that may help improve healthcare for people with long-term conditions in the future. This study aims to provide valuable insights to help healthcare systems better respond to similar crises in the future.

Gender

ALL

Eligibility criteria

• • (For cohort study)
• Inclusion Criteria:
• • People aged 18 years or above with a documented doctor-diagnosed NCDs (diabetes mellitus, hypertension, cardiovascular disease, cancer, chronic kidney disease, or chronic respiratory disease )
• • People who attended at least once HA hospitals, general or specialist out-patients clinics between 1 January 2010 and 31 December 2024
• Exclusion Criteria:
• • - People with a documented doctor-diagnosed COVID-19
• • (For cross-sectional study)
• Inclusion Criteria:
• • People aged 18 years or above with a documented doctor-diagnosed NCDs (diabetes mellitus, hypertension, cardiovascular disease, cancer, chronic kidney disease, or chronic respiratory disease )
• • All participants are able to communicate in either Chinese or English and provide informed consent.
• Exclusion Criteria:
• • People with a documented diagnosis of COVID-19 during the study period.